ruthenium has been researched along with Esophageal Squamous Cell Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Guo, L; Lin, J; Lv, G; Qiu, L; Yang, H; Yu, H; Zhang, L; Zou, M | 1 |
1 other study(ies) available for ruthenium and Esophageal Squamous Cell Carcinoma
| Article | Year |
|---|---|
Insights into anticancer activity and mechanism of action of a ruthenium(II) complex in human esophageal squamous carcinoma EC109 cells.
Topics: Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Calcium; Carcinoma, Squamous Cell; Caspase 3; Caspase 9; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cytochromes c; Down-Regulation; Esophageal Neoplasms; Esophageal Squamous Cell Carcinoma; Humans; Intracellular Space; Membrane Potential, Mitochondrial; Models, Molecular; Molecular Conformation; Organometallic Compounds; Protein Transport; Proto-Oncogene Proteins c-bcl-2; Ruthenium | 2016 |